Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Jouko Uusitalo"'
Autor:
Mika Scheinin, Risto Lammintausta, Camilla Stjernschantz, Jouni Vuorinen, Pasi Tapanainen, Olavi Pelkonen, Terhi Lehtinen, Marita Kailajärvi, Jouko Uusitalo, Miia Turpeinen
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 7, Pp 14064-14075 (2013)
The objective of these investigations was to determine the possible effects of the novel selective estrogen receptor modulator, ospemifene, on cytochrome P450 (CYP)-mediated drug metabolism. Ospemifene underwent testing for possible effects on CYP en
Externí odkaz:
https://doaj.org/article/a788bfc9b5ac408ba34f2b49ea039e71
Publikováno v:
Journal of Essential Oil Research. Mar/Apr2006, Vol. 18 Issue 2, p134-138. 5p.
Autor:
Miia Turpeinen, Mika Scheinin, Terhi Lehtinen, Pasi Tapanainen, Camilla Stjernschantz, Jouni Vuorinen, Marita Kailajärvi, Risto Lammintausta, Olavi Pelkonen, Jouko Uusitalo
Publikováno v:
International Journal of Molecular Sciences
Volume 14
Issue 7
Pages 14064-14075
International Journal of Molecular Sciences, Vol 14, Iss 7, Pp 14064-14075 (2013)
Volume 14
Issue 7
Pages 14064-14075
International Journal of Molecular Sciences, Vol 14, Iss 7, Pp 14064-14075 (2013)
The objective of these investigations was to determine the possible effects of the novel selective estrogen receptor modulator, ospemifene, on cytochrome P450 (CYP)-mediated drug metabolism. Ospemifene underwent testing for possible effects on CYP en
Autor:
Miia Turpeinen, Jouko Uusitalo, Olavi Pelkonen, Ari Tolonen, Pasi Koskimies, Risto Lammintausta
Publikováno v:
Drug Metabolism and Personalized Therapy. 31
Background Metabolite profiles of ospemifene, a novel nonsteroidal selective estrogen receptor modulator, were surveyed as part of its development. Methods The pharmacokinetics of ospemifene and its two major, pharmacologically active metabolites 4-h
Autor:
Jouko Uusitalo, Christophe Chesne, Miia Turpeinen, Olavi Pelkonen, André Guillouzo, Ari Tolonen
Publikováno v:
Toxicology in Vitro. 23:748-753
Practically all human hepatocyte cell lines are deficient in major cytochrome P450 (CYP)-related enzyme activities, making them unrepresentative of in vivo hepatocytes. We have used the recently developed HepaRG cell line to determine the spectrum of
Publikováno v:
Drug Metabolism and Disposition. 35:1135-1141
Timolol has mainly been used topically for the treatment of glaucoma. It has been suggested that the drug is metabolized by cytochrome P450 CYP2D6. The matter has not, however, been extensively studied. The aim here was to tentatively identify timolo
Autor:
Jussi Koivunen, Siri Lehtonen, Miia Turpeinen, Anu Olkku, Anitta Mahonen, Hannu-Ville Leskelä, Petri Lehenkari, Katri S. Selander, Lauri Kangas, Jouko Uusitalo, Olavi Pelkonen
Publikováno v:
Bone. 39:1026-1034
Hormone replacement therapy is effectively used to prevent postmenopausal bone loss. Variation in response to the therapy is, however, frequently seen. In addition, the direct effects of sex steroids on isolated human bone marrow stromal cells have b
Autor:
Jouko Uusitalo, Jukka Mönkkönen, Olavi Pelkonen, Paavo Honkakoski, Miia Turpeinen, Timo Korjamo
Publikováno v:
Pharmaceutical Research. 23:1991-2001
To characterise in detail the patterns of expression and functional activities of CYP and efflux pump genes in Caco-2 cells stably transfected with human Pregnane X Receptor or murine Constitutive Androstane Receptor. Cell lines transfected with nucl
Publikováno v:
Journal of Essential Oil Research. 18:134-138
The effect of harvesting time on the quality and quantity of mint oils produced from plants grown in short summer and long-day climatic conditions of northern Finland (64°40′N and 25°E) was examined to determine what growth stage is best for cutt
Publikováno v:
European Journal of Pharmaceutical Sciences. 25:155-162
A simple but efficient method for determination of labile protons in drug metabolites using post-column infusion of deuterium oxide (D2O) in liquid chromatography/mass spectrometry (LC/MS) experiments with electrospray ionization and time-of-flight m